Biologic Platforms

A biologic treatment that recognizes only a toxic disease-associated form may reduce disease burden with fewer side effects. The platform depends on specificity rather than broad immune suppression. The proposed workflow includes target identification, binder generation, specificity testing, animal evaluation, and cautious movement toward human testing. Biologic technology is framed as a platform for selectively targeting harmful internal molecules.